UA98665C2 - Лекарственный препарат, проявляющий противоопухолевое действие в отношении злокачественных клеток, и способ лечения - Google Patents

Лекарственный препарат, проявляющий противоопухолевое действие в отношении злокачественных клеток, и способ лечения

Info

Publication number
UA98665C2
UA98665C2 UAA201003470A UAA201003470A UA98665C2 UA 98665 C2 UA98665 C2 UA 98665C2 UA A201003470 A UAA201003470 A UA A201003470A UA A201003470 A UAA201003470 A UA A201003470A UA 98665 C2 UA98665 C2 UA 98665C2
Authority
UA
Ukraine
Prior art keywords
medicinal preparation
treatment method
malignant cells
action against
against malignant
Prior art date
Application number
UAA201003470A
Other languages
English (en)
Ukrainian (uk)
Inventor
Геннадий Васильевич Мазильников
Аркадий Петрович Шиманский
Юрий Анатольевич Лиходед
Стефания Стефановна Мельник
Original Assignee
Геннадий Васильевич Мазильников
Аркадий Петрович Шиманский
Лиходид Юрий Анатольевич
Стефания Стефановна Мельник
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Геннадий Васильевич Мазильников, Аркадий Петрович Шиманский, Лиходид Юрий Анатольевич, Стефания Стефановна Мельник filed Critical Геннадий Васильевич Мазильников
Priority to UAA201003470A priority Critical patent/UA98665C2/ru
Priority to PCT/UA2010/000014 priority patent/WO2011119125A1/ru
Publication of UA98665C2 publication Critical patent/UA98665C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к медицине, в частности к онкологии, касается лекарственного препарата, содержащего оксалат лития, диметилксантин и фторурацил, и способа лечения злокачественных опухолей.
UAA201003470A 2010-03-25 2010-03-25 Лекарственный препарат, проявляющий противоопухолевое действие в отношении злокачественных клеток, и способ лечения UA98665C2 (ru)

Priority Applications (2)

Application Number Priority Date Filing Date Title
UAA201003470A UA98665C2 (ru) 2010-03-25 2010-03-25 Лекарственный препарат, проявляющий противоопухолевое действие в отношении злокачественных клеток, и способ лечения
PCT/UA2010/000014 WO2011119125A1 (ru) 2010-03-25 2010-03-26 Применение оксалата лития в производстве лечебного препарата противоопухолевого действия по отношению к злокачественным клеткам, лечебный препарат на его основе и способ лечения

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201003470A UA98665C2 (ru) 2010-03-25 2010-03-25 Лекарственный препарат, проявляющий противоопухолевое действие в отношении злокачественных клеток, и способ лечения

Publications (1)

Publication Number Publication Date
UA98665C2 true UA98665C2 (ru) 2012-06-11

Family

ID=44673472

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201003470A UA98665C2 (ru) 2010-03-25 2010-03-25 Лекарственный препарат, проявляющий противоопухолевое действие в отношении злокачественных клеток, и способ лечения

Country Status (2)

Country Link
UA (1) UA98665C2 (ru)
WO (1) WO2011119125A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013074055A1 (ru) * 2011-11-16 2013-05-23 ШИМАНСКИЙ, Аркадий Петрович Способ оздоровления и омоложения организма человека и фармацевтическая композиция для его осуществления

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6133317A (en) * 1995-11-15 2000-10-17 Hart; Francis J. Oxalic acid or oxalate composition and method of treatment
WO2004026319A2 (en) * 2002-09-17 2004-04-01 Centre National De La Recherche Scientifique Pharmaceutical compositions increasing camp useful for the treatment of cancers
AU2005249200A1 (en) * 2004-06-03 2005-12-15 F. Hoffmann-La Roche Ag Treatment with oxaliplatin and an EGFR-inhibitor
WO2006011007A1 (en) * 2004-07-23 2006-02-02 Om Pharma Combination anticancer therapy and pharmaceutical compositions therefore
ES2373867T3 (es) * 2007-03-02 2012-02-09 The University Of Wollongong Composiciones y procedimientos para el suministro de agentes anticancerosos.

Also Published As

Publication number Publication date
WO2011119125A1 (ru) 2011-09-29

Similar Documents

Publication Publication Date Title
GB201106750D0 (en) Novel compounds
GB201106743D0 (en) Novel compounds
LT2807159T (lt) Nauji indolizino junginiai, jų gamybos būdai ir juos turinčios farmacinės kompozicijos, skirtos vėžio gydymui
PH12013500955A1 (en) Spiro-oxindole mdm2 antagonists
GEP20186816B (en) Anty il-36r antybodies
MX2013008850A (es) Composiciones y metodos para tratar enfermedades cardiovasculares.
MX366804B (es) Translocaciones de la r-espondina y sus metodos de uso.
EP2563426A4 (en) APPLICATION WITH HIGH SCAM FOR MEDICAL THERAPY
MX2014012477A (es) Inhibidores pirrolopirazona de tanquirasa.
MX2013007057A (es) Metodos para producir composiciones farmaceuticas estabilizadas de dosis solida que contienen morfinanos.
IL207310A0 (en) Vaccine compositions
GB2502032A (en) Vitamin D composition
PH12015501088A1 (en) Dimeric compounds
MX359210B (es) Composición de combinación de pac-1 y tamoxifeno.
IN2014MN01944A (ru)
NZ707636A (en) Ingenol-derived compounds that can be used for treating cancer
WO2014083019A3 (en) Agent for modulating the dissemination of cancer cells, product comprising said agent, and use of said agent in the treatment and/or prevention of cancer
MX2013010947A (es) Complejos de galio, composiciones farmacéuticas y métodos de uso.
WO2012173677A3 (en) Anticancer therapeutic agents
GB2528604A (en) Modulation of asymmetric proliferation
UA98666C2 (ru) Лекарственный препарат на основе щавелевой кислоты, проявляющий противоопухолевое действие в отношении злокачественных клеток, и способ лечения
MX351765B (es) Uso de sales de 3-carboxi-n-etil-n,n-dimetilpropan-1-aminio en el tratamiento de enfermedades cardiovasculares.
MX350868B (es) Medicamentos y metodos para tratar cancer.
GB2519004A (en) Quinone compounds and their uses for the treatment of cancer
UA46888U (ru) Способ лечения местнораспространенных форм рака молочной железы